Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Stock-Based Compensation (Tables)

v3.23.3
Stockholders' Equity and Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Stockholders' Equity and Stock-Based Compensation  
Schedule of warrant activity

The following table summarizes warrant activity as of September 30, 2023:

Warrants

Weighted Average

Weighted Average

Contractual Life

Aggregate

    

Shares

    

Exercise Price

    

(in years)

    

Intrinsic Value

Outstanding at January 1, 2023

 

3,220,000

$

5.50

 

4.13

$

Granted

 

$

 

$

Exercised

 

(2,200)

$

5.50

 

$

Canceled

 

$

 

$

Outstanding at September 30, 2023

 

3,217,800

$

5.50

 

3.38

$

Exercisable at September 30, 2023

 

3,217,800

Schedule of stock option activity

Stock Options

    

    

    

Weighted Average

    

Weighted Average

Contractual Life

Aggregate

Shares

Exercise Price

(in years)

Intrinsic Value

Outstanding at January 1, 2023

 

254,000

$

1.69

 

8.76

 

$

193,486

Granted

 

135,015

$

3.96

 

9.47

$

24,303

Exercised

 

(133)

$

1.62

 

$

93

Forfeited

 

(26,215)

$

2.22

 

$

33,550

Outstanding at September 30, 2023

 

362,667

$

2.49

 

8.98

$

207,788

Vested and exercisable at September 30, 2023

 

77,130

$

1.62

 

8.71

$

68,837

Schedule of RSU activity and related information

Restricted Stock Units

Weighted Average

Grant Date Fair Value

    

Number of Shares

    

per Share

Unvested- January 1, 2023

352,764

$

1.67

Granted

 

310,599

$

3.77

Vested

(110,184)

$

1.67

Forfeited

 

(26,215)

$

2.22

Unvested- September 30, 2023

 

526,964

$

2.88